Literature DB >> 3126062

Comparative in vitro activity of cefetamet and fleroxacin against anaerobic bacteria.

J Wüst1, U Hardegger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3126062     DOI: 10.1007/bf02013075

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents.

Authors:  N Manek; J M Andrews; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

2.  In vitro activity of RO 15-8074 and RO 19-5247.

Authors:  T Valle; E Jalanko; L Scheinin; O V Renkonen
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

Review 3.  Antimicrobial susceptibility testing of anaerobic bacteria.

Authors:  J E Rosenblatt
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

Review 4.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

5.  The comparative in-vitro activity of eight newer quinolones and nalidixic acid.

Authors:  A King; I Phillips
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

  5 in total
  5 in total

Review 1.  Fleroxacin clinical pharmacokinetics.

Authors:  A E Stuck; D K Kim; F J Frey
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

Review 2.  Quinolone activity against anaerobes.

Authors:  P C Appelbaum
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 3.  Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  H M Bryson; R N Brogden
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

Review 4.  Quinolone activity against anaerobes: microbiological aspects.

Authors:  P C Appelbaum
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 5.  Developments in quinolones. Bacteriology, pharmacokinetics and initial clinical experience of several investigational quinolone derivatives.

Authors:  R Janknegt; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1989-04-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.